No hay productos en el carrito



Optical Coherence Tomography in Neurologic Diseases
Calabresi, P. — Balcer, L. — Frohman, E.
1ª Edición Mayo 2015
Inglés
Tapa dura
228 pags
701 gr
20 x 25 x 2 cm
ISBN 9781107041301
Editorial CAMBRIDGE
LIBRO IMPRESO
-5%
181,02 €171,97 €IVA incluido
174,06 €165,36 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
Description
Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account of the clinical applications of OCT.
- The first comprehensive review of the clinical use of OCT in a wide range of neurological diseases
- Practical, reflecting the rapid move of OCT into routine office practice
- Extensively illustrated in color, with sample case-histories and the expertise of leading physicians
Contents
Preface
  1. Introduction to optical coherence tomography in neurological diseases Peter 
  A. Calabresi, Laura J. Balcer and Elliot M. Frohman
  2. Basic principles of optical coherence tomography Sven Schippling
  3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta 
  and Sashank Prasad
  4. Optical coherence tomography in acute optic neuritis Andrew P. D. Henderson, 
  S. Anand Trip and David H. Miller
  5. Optical coherence tomography and visual outcomes in acute optic neuritis 
  Fiona Costello
  6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura 
  J. Balcer
  7. Optical coherence tomography and electrophysiology of the visual pathway 
  A. Klistorner, C. L. Fraser, C. Yiannikas and S. L. Graham
  8. Optical coherence tomography and electrophysiology of the optic nerve head 
  Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, 
  Elliot M. Frohman and Teresa C. Frohman
  9. Meta-analysis of optical coherence tomography in multiple sclerosis Axel 
  Petzold
  10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha 
  and Peter A. Calabresi
  11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul 
  and Alexander Ulrich Brandt
  12. Optical coherence tomography pathologies to know about in clinical practice 
  Scott Newsome and John N. Ratchford
  13. Optical coherence tomography and retinal segmentation in neurological diseases 
  Elias S. Sotirchos and Shiv Saidha
  14. Optical coherence tomography and retinal pathology in neurologic diseases 
  Ari J. Green
  15. Retinal inflammation in MS revealed by optical coherence tomography and 
  ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo 
  Villoslada
  16. Optical coherence tomography and optic nerve MRI in demyelinating diseases 
  Robert T. Naismith
  17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel 
  and Peter K. Kaiser
  18. Optical coherence tomography in multi-center setting: quality control issues 
  Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. 
  Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and 
  Pablo Villoslada
  19. Future technological advances in optical coherence tomography Hiroshi Ishikawa 
  and Joel Schuman
  Index.
Authors
Peter A. Calabresi, Department of Neurology, Johns Hopkins University Hospital, 
  Baltimore
  Peter A. Calabresi is Professor of Neurology, Director of the Richard T. Johnson 
  Division of Neuroimmunology and Neuroinfectious Diseases, and Director of the 
  Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of 
  Medicine, Baltimore, Maryland, USA.
Laura J. Balcer, Department of Neurology, NYU Langone Medical Center, New York
  Laura J. Balcer is Professor and Vice Chair, Department of Neurology, New York 
  University Langone Medical Center, New York, USA.
Elliot M. Frohman, Department of Neurology, UT Southwestern Medical Center, 
  Dallas
  Elliot M. Frohman is a Professor of Neurology, Department of Neurology, University 
  of Texas Southwestern Medical Center, Dallas, Texas, USA.
© 2025 Axón Librería S.L.
2.149.0